ASKG915
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASKG915, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ASKG915 in Patients With Selected Advanced Solid Tumors. [Phase 1, Phase 2]